BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 27600331)

  • 1. Dabigatran antagonizes growth, cell-cycle progression, migration, and endothelial tube formation induced by thrombin in breast and glioblastoma cell lines.
    Vianello F; Sambado L; Goss A; Fabris F; Prandoni P
    Cancer Med; 2016 Oct; 5(10):2886-2898. PubMed ID: 27600331
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thrombin induces tumor cell cycle activation and spontaneous growth by down-regulation of p27Kip1, in association with the up-regulation of Skp2 and MiR-222.
    Hu L; Ibrahim S; Liu C; Skaar J; Pagano M; Karpatkin S
    Cancer Res; 2009 Apr; 69(8):3374-81. PubMed ID: 19351827
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of thrombin-bound dabigatran effects on protease-activated receptor-1 expression and signaling in vitro.
    Chen B; Soto AG; Coronel LJ; Goss A; van Ryn J; Trejo J
    Mol Pharmacol; 2015 Jul; 88(1):95-105. PubMed ID: 25934730
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thrombin induces protease-activated receptor 1 signaling and activation of human atrial fibroblasts and dabigatran prevents these effects.
    Altieri P; Bertolotto M; Fabbi P; Sportelli E; Balbi M; Santini F; Brunelli C; Canepa M; Montecucco F; Ameri P
    Int J Cardiol; 2018 Nov; 271():219-227. PubMed ID: 29801760
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thrombin inhibition by dabigatran attenuates endothelial dysfunction in diabetic mice.
    Rahadian A; Fukuda D; Salim HM; Yagi S; Kusunose K; Yamada H; Soeki T; Shimabukuro M; Sata M
    Vascul Pharmacol; 2020 Jan; 124():106632. PubMed ID: 31759113
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thrombin inhibition and cyclophosphamide synergistically block tumor progression and metastasis.
    Alexander ET; Minton AR; Hayes CS; Goss A; Van Ryn J; Gilmour SK
    Cancer Biol Ther; 2015; 16(12):1802-11. PubMed ID: 26383051
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The direct oral anticoagulants rivaroxaban and dabigatran do not inhibit orthotopic growth and metastasis of human breast cancer in mice.
    Buijs JT; Laghmani EH; van den Akker RFP; Tieken C; Vletter EM; van der Molen KM; Crooijmans JJ; Kroone C; Le Dévédec SE; van der Pluijm G; Versteeg HH
    J Thromb Haemost; 2019 Jun; 17(6):951-963. PubMed ID: 30929299
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thrombin Signaling Contributes to High Glucose-Induced Injury of Human Brain Microvascular Endothelial Cells.
    Vittal Rao H; Bihaqi SW; Iannucci J; Sen A; Grammas P
    J Alzheimers Dis; 2021; 79(1):211-224. PubMed ID: 33252072
    [TBL] [Abstract][Full Text] [Related]  

  • 9. p27Kip1 and cyclin D1 are necessary for focal adhesion kinase regulation of cell cycle progression in glioblastoma cells propagated in vitro and in vivo in the scid mouse brain.
    Ding Q; Grammer JR; Nelson MA; Guan JL; Stewart JE; Gladson CL
    J Biol Chem; 2005 Feb; 280(8):6802-15. PubMed ID: 15557280
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of pro-inflammatory genes in human endothelial cells: Comparison of rivaroxaban and dabigatran.
    Ellinghaus P; Perzborn E; Hauenschild P; Gerdes C; Heitmeier S; Visser M; Summer H; Laux V
    Thromb Res; 2016 Jun; 142():44-51. PubMed ID: 27131284
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of PAR-1 in patients with non-valvular atrial fibrillation: The antiplatelet effect of dabigatran.
    Oi K; Shimizu M; Natori T; Tsuda K; Yoshida M; Kamada A; Ishigaku Y; Narumi S; Oura K; Maeda T; Terayama Y
    Thromb Res; 2021 May; 201():123-130. PubMed ID: 33667955
    [TBL] [Abstract][Full Text] [Related]  

  • 12. miR‑296‑3p promotes the proliferation of glioblastoma cells by targeting ICAT.
    Zhou J; Du G; Fu H
    Mol Med Rep; 2020 May; 21(5):2151-2161. PubMed ID: 32323769
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phytosomal-curcumin antagonizes cell growth and migration, induced by thrombin through AMP-Kinase in breast cancer.
    Hashemzehi M; Behnam-Rassouli R; Hassanian SM; Moradi-Binabaj M; Moradi-Marjaneh R; Rahmani F; Fiuji H; Jamili M; Mirahmadi M; Boromand N; Piran M; Jafari M; Sahebkar A; Avan A; Khazaei M
    J Cell Biochem; 2018 Jul; 119(7):5996-6007. PubMed ID: 29600521
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dabigatran mitigates cisplatin-mediated nephrotoxicity through down regulation of thrombin pathway.
    Ewees MGE; Abdel-Bakky MS; Bayoumi AMA; Abo-Saif AA; Altowayan WM; Alharbi KS; Messiha BAS
    J Adv Res; 2021 Jul; 31():127-136. PubMed ID: 34194837
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting DYRK1A/B kinases to modulate p21-cyclin D1-p27 signalling and induce anti-tumour activity in a model of human glioblastoma.
    Massey AJ; Benwell K; Burbridge M; Kotschy A; Walmsley DL
    J Cell Mol Med; 2021 Nov; 25(22):10650-10662. PubMed ID: 34708541
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of rivaroxaban and dabigatran on local expression of coagulation and inflammatory factors within human aortic stenotic valves.
    Wypasek E; Natorska J; Mazur P; Kopytek M; Gawęda B; Kapusta P; Madeja J; Iwaniec T; Kapelak B; Undas A
    Vascul Pharmacol; 2020 Jul; 130():106679. PubMed ID: 32387621
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dabigatran, a direct thrombin inhibitor, demonstrates antifibrotic effects on lung fibroblasts.
    Bogatkevich GS; Ludwicka-Bradley A; Silver RM
    Arthritis Rheum; 2009 Nov; 60(11):3455-64. PubMed ID: 19877031
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential expression of miR16 in glioblastoma and glioblastoma stem cells: their correlation with proliferation, differentiation, metastasis and prognosis.
    Tian R; Wang J; Yan H; Wu J; Xu Q; Zhan X; Gui Z; Ding M; He J
    Oncogene; 2017 Oct; 36(42):5861-5873. PubMed ID: 28628119
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chrysophanol inhibits proliferation and induces apoptosis through NF-κB/cyclin D1 and NF-κB/Bcl-2 signaling cascade in breast cancer cell lines.
    Ren L; Li Z; Dai C; Zhao D; Wang Y; Ma C; Liu C
    Mol Med Rep; 2018 Mar; 17(3):4376-4382. PubMed ID: 29344652
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isorhapontigenin suppresses growth of patient-derived glioblastoma spheres through regulating miR-145/SOX2/cyclin D1 axis.
    Xu Z; Zeng X; Xu J; Xu D; Li J; Jin H; Jiang G; Han X; Huang C
    Neuro Oncol; 2016 Jun; 18(6):830-9. PubMed ID: 26681767
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.